With a robust academic background including an MBA in Finance from NYU-Stern, and an MD from Delhi University, my journey in the financial world has been diverse and enriching. My postgraduate training in medicine was conducted at Harvard and Cornell, thus laying a solid foundation for my current expertise.As a registered investment advisor and professional money manager, I bring nearly a decade of experience in writing about income investing and biotech/pharma investing. My role at Vasuda Healthcare Analyt ...

Key TakeawaysNovo Nordisk's U.S.-listed shares lost ground Friday after a Phase 2a trial of the pharmaceutical firm’s latest obesity treatment showed less effectiveness in higher doses.Based on the results, Novo Nordisk said it would be initiating a larger Phase 2b study next year.Novo Nordisk shares were down over 5% in intraday trading Friday, though even with Friday's losses, they've gained more than 22% since the start of the year. Novo Nordisk's (NVO) U.S.-listed shares lost ground Friday after a study ...

The U.S. housing market is trying to bounce back after a difficult 2023 and the first half of this year. Homebuilder confidence rebounded in September after hitting a low in the past four months. Also, housing starts and building permits rebounded, bringing a glimmer of hope to the housing sector.The Federal Reserve’s rate cut is going to help the sector in the near term as mortgage rates are likely to decline further. It would thus be prudent to invest in homebuilding stocks. We have narrowed our search to ...

Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 1,256,734 shares of its common stock originally issued in March 2024 and having an original exercise price of $5.50 per share, at a reduced exercise price of $2.58 per share. The issuan ...

The nuclear energy sector comprises companies involved in the production of nuclear power and related technologies. These firms range from uranium miners to nuclear plant operators and equipment manufacturers. Nuclear energy stocks represent ownership in these companies traded on public exchanges. The sector has gained renewed attention due to its potential role in reducing carbon emissions. Nuclear power offers a reliable, low-emission source of baseload electricity.Investing in nuclear energy stocks can p ...

 -Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase the health span for the rapidly growing global aging population.    -Late-stage, diversified pipeline of therapeutic candidates across ophthalmology, cardiovascular disease and soft tissue reconstruction and repair.    -Near-term clinical milestones include Phase ...

The announcement that Nike Inc NKE is bringing in Elliot Hill as the new CEO could be a positive change given his experience and company tenure, but it raises questions about the company’s strategy for a turnaround and plans to return to revenue growth.The Nike Analysts: Piper Sandler analyst Anna Andreeva maintained a Neutral rating with a $80 price target.KeyBanc analyst Ashley Owens maintained a Sector Weight rating with no price target.Stifel analyst Jim Duffy maintained a Hold rating with a $79 price t ...

Petroleo Brasileiro S.A. - Petrobras (NYSE: PBR ) is a highly profitable, diversified energy firm with a favorable distribution policy and a low valuation based off of earnings. The energy company benefited from modest growth in its production and itsAnalyst’s Disclosure: I/we have a beneficial long position in the shares of PBR, XOM, CVX, BP either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (o ...

Apple Inc AAPL investors are bracing for a significant shake-up as the quarterly rebalancing of market index funds coincides with a rare triple witching event, a financial phenomenon that only intensifies market volatility.Busiest Rebalancing In Four Years To Boost Apple With $250 billion in stock adjustments underway, the iPhone manufacturer could emerge as one of the biggest beneficiaries. A notable shift comes from Berkshire Hathaway BRK BRK trimming its stake, increasing the share count used by index pr ...

Yesterday, Darden Restaurants, Inc. DRI reported first-quarter adjusted earnings per share of $1.75, missing the analyst consensus estimate of $1.83. Quarterly sales of $2.76 billion missed the street view of $2.80 billion.Analysts covering the company provided their takes:KeyBanc Capital Markets analyst Eric Gonzalez reiterated the Overweight rating on the stock, raising the price forecast to $194 from $170.BMO Capital Markets analyst Andrew Strelzik maintained the Market Perform rating, raising the price ...